Lacosamide in Neonatal Status Epilepticus

• Status: Recruiting
• Trial end date: 2024-04-01
• Target enrollment: 0
• Participant gender: All

Summary

Lacosamide in neonatal status epilepticus

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sherief Abd-Elsalam
• Treatments: Lacosamide; Phenobarbital

Criteria

Inclusion Criteria:

• neonates with status epilepticus

Exclusion Criteria:

• congenital anomalies or organ dysfunction